glutathione in ovarian cancer a double-edged sword

glutathione in ovarian cancer a double-edged sword Ferroptosis: mediating immune tolerance of Glutathione responsive nanomedicine leverages tumor

Name: glutathione in ovarian cancer a double-edged sword Ferroptosis: mediating immune tolerance of Glutathione responsive nanomedicine leverages tumor
Brand: executiveoutsourcing.co.ke
SKU: 1969335243
Price: 29.88 USD
Availability: InStock
Rating: 4.2223 (5 reviews)

Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link N Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives PMC FerroptosisThe Double Edged Sword in Cancer: Mechanisms of Tumor Suppression Resistance and Therapeutic Manipulation Frontiers The versatile utility of cysteine as a target for cancer treatment

SKU: 1969335243 · From executiveoutsourcing.co.ke

4.2

USD29.88 USD79.88

Pay in 4 interest-free payments of $7.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Dominari et al., 2021

This tripeptide compound made up of amino acids - L-glutamate, L-cysteine and glycine - plays a key role in protecting cells from harmful free radicals and oxidative stress

TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells

157 ACADSB negatively regulates the expression of GPX4 and glutathione reductase in colon cancer cells, and overexpression of ACADSB increases the concentration of MDA, Fe 2+ and lipid peroxides, inducing cell ferroptosis, and inhibiting the migration and invasion of CRC cells